DUBLIN--(BUSINESS WIRE)--The "Global Immunoassay Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
Segmentation
By Technology
- Radioimmunoassay (RIA)
- Counting Immunoassay (CIA)
- Enzyme Immunoassays (EIA) or Enzyme-linked Immunosorbent Assays (ELISA)
- Fluoroimmnoassay (FIA)
- Chemiluminescence Immunoassay (CLIA)
By Therapeutic Area
- Infectious Diseases
- Bone Metabolism
- Immunology
- Neurobiology
- Others
By End-User Industry
- Hospitals and Clinics
- Diagnostics
- Pharmaceutical and Biotechnology Companies
- Research & Academic Laboratories
By Geography
- North America
- South America
- Europe
- Middle East and Africa
- Asia Pacific
Key Topics Covered
1. Introduction
2. Research Methodology
3. Key Findings of the Study
4. Market Dynamics
5. Global Immunoassay Market Forecast by Technique
6. Global Immunoassay Market Forecast by Therapeutic Area
7. Global Immunoassay Market Forecast by End-User
8. Global Immunoassay Market Forecast by Geography
9. Competitive Intelligence
10. Company Profiles
- Fujirebio
- Quidel Corporation
- Roche Diagnostics
- Immunodiagnostic Systems
- Arbor Assays
- Omega Diagnostics Group PLC
- Beckman Coulter, Inc.
- ImmunoReagents, Inc.
- Aushon BioSystems
- Mercodia AB
For more information about this report visit https://www.researchandmarkets.com/research/6q7vcz/global?w=4